how do glp 1 drugs work for weight loss The GLP-1 revolution: What UAB researchers are discovering about these GLP-1 Medications Infographic | Medidex

Anti-obesity drug also protects against heart diseasewhat happens next

However, this pioneering approach was futile due to the relatively thick mucosal barrier and continuous flow of saliva

It has been observed that exposure to highly palatable foods increases key neuroendocrine signals, which remodel brain reward circuits to reinforce pathological eating behaviors

The incretin effect of GLP-1 leads to a marked postprandial increase in circulating levels, which enhances insulin secretion.23,24 Elevated postprandial GLP-1 concentrations may be influenced by mechanical stimuli such as gastric distension,3,25 which also activates GLP-1-expressing neurons in the nucleus tractus solitarius (NTS).26 These responses may involve oxytocin-mediated vagal afferent signaling and contribute to the central GLP-1 systems role in promoting a negative energy balance.27,28 Beyond mechanical stimuli, classical satiety hormones, such as cholecystokinin, augment both central GLP-1 neuronal activity and peripheral GLP-1 release;29 however, the concentrations of cholecystokinin required to stimulate peripheral GLP-1 secretion may exceed physiological levels.30 GLP-1 secretion is modulated by various peptides, neurotransmitters, and nutrients, including carbohydrates, lipids, proteins, and amino acids, highlighting the complexity of its regulatory mechanisms.3,31 GLP-1 exerts its effects via the G-protein-coupled receptor,32,33 which is expressed on pancreatic beta cells as well as neurons within the central and peripheral nervous systems

For the purpose of the database, patent families are grouped by number (e.g., Family 1, 5, 30, etc.)